Inulin Hydrogel Loaded with Self-Assembled Nanoparticles of Curcumin and Glycyrrhizic Acid for Inflammatory Bowel Disease Treatment via Anti-Inflammation, Antioxidation, and Microbiota Modulation
Molecular Pharmaceutics · 01.09.2025 · 22 (9) · 5410-5427
DOI: 10.1021/acs.molpharmaceut.5c00383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 20.08.2025. Verfasst von Jiaxin Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory on Technologies Enabling Devel…. Hauptthemen laut MEDLINE: Curcumin, Glycyrrhizic Acid, Nanoparticles, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Tianjin Municipal Education Commission.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) management remains challenging due to the inadequate efficacy and systemic toxicity of conventional therapies. Herein, we developed an inulin hydrogel loaded with self-assembled nanoparticles of curcumin and glycyrrhizic acid (CURG@IN) for IBD treatment. CURG@IN exhibited remarkable gel characteristics and enzyme-responsive drug release behavior. In vitro, CURG@IN demonstrated potent antioxidant capabilities, effectively protecting cells from oxidative injury, facilitating wound healing of epithelial cells, and regulating macrophage polarization. Additionally, it exerted inhibitory effects on the NF-κB pathway, thereby reducing the production of inflammatory cytokines. In DSS-induced colitis mice, oral CURG@IN significantly ameliorated disease activity index and restored colonic histological architecture. Gut barrier integrity was reinforced through upregulation of tight junction proteins, while microbiota analysis revealed significant restoration of microbial homeostasis. Notably, no significant toxicity was observed during treatment. Collectively, this oral therapeutic strategy provides a multimechanistic approach combining anti-inflammatory, antioxidative, and microbiota-modulating effects for safe IBD therapy, with the potential for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School…
- Department of Integrated Traditional Chinese and Western Medicine, International Medical School, Tianjin Medical University, Tianjin 300070, China.
- Department of Pharmacy, Chest Hospital, Tianjin University, Tianjin 300051, China.
- Tianjin Key Laboratory of Oral Soft and Hard Tissues Restoration and Regeneration, School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, China.
ORCID-Profile: Yinsong Wang, Chunyu Li
Förderung
- Tianjin Municipal Education Commission
Zitieren
APA
Wu, J., Wang, L., Lu, H., Huo, Y., Guo, Z., Cheng, Y., Li, Y., Wang, Y., & Li, C. (2025). Inulin Hydrogel Loaded with Self-Assembled Nanoparticles of Curcumin and Glycyrrhizic Acid for Inflammatory Bowel Disease Treatment via Anti-Inflammation, Antioxidation, and Microbiota Modulation. Molecular Pharmaceutics, 22(9), 5410-5427. https://doi.org/10.1021/acs.molpharmaceut.5c00383
Vancouver
Wu J, Wang L, Lu H, Huo Y, Guo Z, Cheng Y, et al. Inulin Hydrogel Loaded with Self-Assembled Nanoparticles of Curcumin and Glycyrrhizic Acid for Inflammatory Bowel Disease Treatment via Anti-Inflammation, Antioxidation, and Microbiota Modulation. Molecular Pharmaceutics. 2025;22(9):5410-5427. doi:10.1021/acs.molpharmaceut.5c00383
BibTeX
@article{Wu2025,
author = {Wu, Jiaxin and Wang, Leyan and Lu, Han and Huo, Yujia and Guo, Zhaoyang and Cheng, Yuanyuan and Li, Yunan and Wang, Yinsong and Li, Chunyu},
title = {Inulin Hydrogel Loaded with Self-Assembled Nanoparticles of Curcumin and Glycyrrhizic Acid for Inflammatory Bowel Disease Treatment via Anti-Inflammation, Antioxidation, and Microbiota Modulation},
journal = {Molecular Pharmaceutics},
year = {2025},
volume = {22},
number = {9},
pages = {5410--5427},
doi = {10.1021/acs.molpharmaceut.5c00383}
}
EUVIMED